In a major advancement in nanomedicine, nanorobots were programmed to target and destroy tumors.
Each nanorobot is made from a flat, rectangular DNA origami sheet that is 90 nanometres by 60 nanometres in size.
Use of Nanotechnology in Healthcare
Nanotechnology provides several potential solutions for many life-threatening diseases. Learn more about the role of nanotechnology in healthcare
Advertisement
‘First fully autonomous, DNA robotic system for a very precise drug design and targeted cancer therapy developed.’
Tweet it Now
Once bound to the tumor blood vessel surface, the nanorobot was programmed to deliver its unsuspecting drug cargo in the very heart of the tumor, exposing an enzyme called thrombin that is key to blood clotting.
The nanorobots worked fast, congregating in large numbers to quickly surround the tumor just hours after injection.
The treatment blocked blood supply to the tumor and generated tumor tissue damage within 24 hours while having no effect on healthy tissues.
![Test Your Knowledge on Liver Cancer]( "Test Your Knowledge on Liver Cancer")
Primary hepatocellular carcinoma is a cancer that starts in the liver. The liver is the largest organ in the body situated in the upper right quadrant of the abdomen. The liver is also a common site for cancer deposits (metastases) from other organs. This is referred to as secondary liver cancer and is more common than primary liver cancer.
After attacking tumors, most of the nanorobots were cleared and degraded from the body after 24 hours.
The median survival time is more than doubled, extending from 20.5 to 45 days.
"Moreover, this technology is a strategy that can be used for many types of cancer, since all solid tumor-feeding blood vessels are essentially the same," said Hao Yan, Professor and Director at Arizona State University, in a paper published in the journal Nature Biotechnology.
Until now, the challenge to advancing nanomedicine has been difficult because scientists wanted to design, build and carefully control nanorobots to actively seek and destroy cancerous tumors, while not harming any healthy cells.
However, the new "nanorobots can be programmed to transport molecular payloads and cause on-site tumor blood supply blockages, which can lead to tissue death and shrink the tumor", explained Baoquan Ding, Professor at the National Centre for Nanoscience and Technology (NCNST) in China.
For the study, the team used a melanoma mouse model, where the nanorobot not only affected the primary tumor but also prevented the formation of metastasis, showing promising therapeutic potential.
Importantly, the nanorobots were found safe and effective in shrinking tumors and there was no evidence of the nanorobots spreading into the brain where it could cause unwanted side-effects, such as a stroke.
"The thrombin delivery DNA nanorobot constitutes a major advance in the application of DNA nanotechnology for cancer therapy," Yan said.
Source: IANS
The treatment blocked blood supply to the tumor and generated tumor tissue damage within 24 hours while having no effect on healthy tissues.
Test Your Knowledge on Liver Cancer
Primary hepatocellular carcinoma is a cancer that starts in the liver. The liver is the largest organ in the body situated in the upper right quadrant of the abdomen. The liver is also a common site for cancer deposits (metastases) from other organs. This is referred to as secondary liver cancer and is more common than primary liver cancer.
Advertisement
After attacking tumors, most of the nanorobots were cleared and degraded from the body after 24 hours.
The median survival time is more than doubled, extending from 20.5 to 45 days.
"Moreover, this technology is a strategy that can be used for many types of cancer, since all solid tumor-feeding blood vessels are essentially the same," said Hao Yan, Professor and Director at Arizona State University, in a paper published in the journal Nature Biotechnology.
Until now, the challenge to advancing nanomedicine has been difficult because scientists wanted to design, build and carefully control nanorobots to actively seek and destroy cancerous tumors, while not harming any healthy cells.
However, the new "nanorobots can be programmed to transport molecular payloads and cause on-site tumor blood supply blockages, which can lead to tissue death and shrink the tumor", explained Baoquan Ding, Professor at the National Centre for Nanoscience and Technology (NCNST) in China.
For the study, the team used a melanoma mouse model, where the nanorobot not only affected the primary tumor but also prevented the formation of metastasis, showing promising therapeutic potential.
Importantly, the nanorobots were found safe and effective in shrinking tumors and there was no evidence of the nanorobots spreading into the brain where it could cause unwanted side-effects, such as a stroke.
"The thrombin delivery DNA nanorobot constitutes a major advance in the application of DNA nanotechnology for cancer therapy," Yan said.
Source: IANS
Lifetime Risk Calculator for Cancers
What are your chances for developing some common cancers in your lifetime - find out now.
Advertisement
 Cancer Prevention thro' Lifestyle ChangesDid u know that simple changes in lifestyle could lower your cancer risks? Find out how! | Advertisement
|
Advertisement
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.